Usage: Larin 24 Fe is indicated for women to prevent pregnancy. Its efficacy in women with a body mass index (BMI) greater than 35 kg/m² has not been evaluated.
Usage: Natazia® is indicated for preventing pregnancy in women and for treating heavy menstrual bleeding in those without organic pathology who prefer an oral contraceptive. Efficacy in women with a BMI over 30 kg/m² has not been evaluated.
Usage: Tydemy™ is indicated for females of reproductive potential to prevent pregnancy and for folate supplementation to reduce the risk of neural tube defects in pregnancies conceived while using the product or shortly after discontinuation.
Usage: Xulane is indicated for preventing pregnancy in women with a body mass index (BMI) < 30 kg/m², where a combined hormonal contraceptive is appropriate. It may be less effective for women weighing 198 lbs. (90 kg) or more and is contraindicated for those with a BMI ≥ 30 kg/m².
Usage: ZAFEMY® is indicated for the prevention of pregnancy in women with a BMI < 30 kg/m², suitable for those who can use a combined hormonal contraceptive. It may be less effective in women weighing 198 lbs or more and is contraindicated in women with a BMI ≥ 30 kg/m².